Response to letter entitled: Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials

被引:2
|
作者
Agostinetto, Elisa [1 ,2 ,3 ,7 ]
Ceppi, Marcello [4 ]
Bruzzone, Marco [4 ]
Lambertini, Matteo [5 ,6 ]
de Azambuja, Evandro [1 ,2 ]
机构
[1] Inst Jules Bordet, Acad Trials Promoting Team, Blvd Waterloo 121, B-1000 Brussels, Belgium
[2] Univ Libre Bruxelles ULB, Brussels, Belgium
[3] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Med Oncol & Hematol Unit, Milan, Italy
[4] IRCCS Osped Policlin San Martino, Unit Clin Epidemiol, Genoa, Italy
[5] Univ Genoa, Sch Med, Dept Internal Med & Med Specialties DiMI, Genoa, Italy
[6] IRCCS Osped Policlin San Martino, Dept Med Oncol, UO Clin Oncol Med, Genoa, Italy
[7] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20090 Pieve Emanuele Milan, Italy
关键词
D O I
10.1016/j.ejca.2021.06.042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:303 / 306
页数:4
相关论文
共 50 条
  • [41] Association between sex and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
    Lai, Jianxiong
    Kuang, Xiaohong
    Fu, Yi
    Li, Jian
    IMMUNOTHERAPY, 2024, 16 (07) : 481 - 495
  • [42] Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis
    Li, Song
    Xu, Qian
    Dai, Xin
    Zhang, Xue
    Huang, Miao
    Huang, Kai
    Shi, Duanbo
    Wang, Jian
    Liu, Lian
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (06) : 3594 - 3602
  • [43] Efficacy and Safety of Immune Checkpoint Inhibitors for Cervical Cancer: A Systematic Review and Meta-Analysis
    Zhang, Xian
    Zhan, Yuejuan
    Zhou, Yannan
    Liu, Chang
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (08):
  • [44] Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis
    Sahin, Taha Koray
    Guven, Deniz Can
    CLINICAL NUTRITION ESPEN, 2024, 63 : 829 - 836
  • [45] Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis
    Song Li
    Qian Xu
    Xin Dai
    Xue Zhang
    Miao Huang
    Kai Huang
    Duanbo Shi
    Jian Wang
    Lian Liu
    Annals of Surgical Oncology, 2023, 30 : 3594 - 3602
  • [46] Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis
    Wang, Daniel Y.
    Salem, Joe-Elie
    Cohen, Justine V.
    Chandra, Sunandana
    Menzer, Christian
    Ye, Fei
    Zhao, Shilin
    Das, Satya
    Beckermann, Kathryn E.
    Ha, Lisa
    Rathmell, W. Kimryn
    Ancell, Kristin K.
    Balko, Justin M.
    Bowman, Caitlin
    Davis, Elizabeth J.
    Chism, David D.
    Horn, Leora
    Long, Georgina V.
    Carlino, Matteo S.
    Lebrun-Vignes, Benedicte
    Eroglu, Zeynep
    Hassel, Jessica C.
    Menzies, Alexander M.
    Sosman, Jeffrey A.
    Sullivan, Ryan J.
    Moslehi, Javid J.
    Johnson, Douglas B.
    JAMA ONCOLOGY, 2018, 4 (12) : 1721 - 1728
  • [47] Cardiovascular events with immune checkpoint inhibitors in melanoma or NSCLC: A systematic review and meta-analysis
    Mandala, M.
    Becattini, C.
    Roila, F.
    Agnelli, G.
    Giustozzi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1179 - S1180
  • [48] Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
    Xu, Cheng
    Chen, Yu-Pei
    Du, Xiao-Jing
    Liu, Jin-Qi
    Huang, Cheng-Long
    Chen, Lei
    Zhou, Guan-Qun
    Li, Wen-Fei
    Mao, Yan-Ping
    Hsu, Chiun
    Liu, Qing
    Lin, Ai-Hua
    Tang, Ling-Long
    Sun, Ying
    Ma, Jun
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [49] Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis
    Sahin, T. K.
    Guven, D. C.
    ANNALS OF ONCOLOGY, 2024, 35 : S1091 - S1091
  • [50] Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Zhao, Mei
    Chen, Shanwen
    Li, Conggui
    Du, Yingying
    Li, Ping
    CANCERS, 2023, 15 (03)